Duration of dual antiplatelet therapy after myocardial infarction: Insights from a pooled database of the SMART-DATE and DAPT-STEMI trials-Reference-Cited by-同舟云学术

Duration of dual antiplatelet therapy after myocardial infarction: Insights from a pooled database of the SMART-DATE and DAPT-STEMI trials

Published:2020-12 Issue: Volume:315 Page:55-61
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Kedhi Elvin,Delewi Ronak^ORCID,Fabris Enrico,De Luca Giuseppe,Hermanides Renicus S.,van den Ent Martin,Buszman Pawel,Zijlstra Felix,Song Young Bin^ORCID,Gwon Hyeon-Cheol,Hahn Joo-Yong

Funder

Abbott Vascular

Biotronik

Boston Scientific

Medtronic

AstraZeneca

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials;De Luca;Arch. Intern. Med.,2012

2. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial;Kedhi;Lancet,2010

3. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease;Stone;N. Engl. J. Med.,2010

4. Everolimus-eluting stents and paclitaxel-eluting stents in patients presenting with myocardial infarction: insights from the two-year results of the COMPARE prospective randomised controlled trial;Kedhi;EuroIntervention,2012

5. Everolimus eluting stent vs first generation drug-eluting stent in primary angioplasty: a pooled patient-level meta-analysis of randomized trials;De Luca;Int. J. Cardiol.,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease: 2023 Update;Global Heart;2024

2. Gender differences in efficacy and safety of antiplatelet strategies for acute coronary syndromes;Expert Opinion on Drug Safety;2023-08-03

3. Tailoring oral antiplatelet therapy in acute coronary syndromes: from guidelines to clinical practice;Journal of Cardiovascular Medicine;2022-11-15

4. Aspirin with Low-Dose Ticagrelor or with Low-Dose Rivaroxaban for Secondary Prevention: A Cost per Outcome Analysis;American Journal of Cardiovascular Drugs;2022-07-23